Fecal Microbiota Transplantation for Epilepsy

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Increasing evidences showed the microbiota effects on neuropsychiatric disorders. This clinical trial aims to evaluate the efficacy and safety of fecal microbiota transplantation for epilepsy.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Second Hospital of Nanjing Medical University

Criteria

Inclusion Criteria:

• epilepsy diagnosed by typical electroencephalogram (EEG) and Magnetic resonance imaging (MRI)

• frequent relapses of epilepsy (> one seizure per 6 months) at a stabilize extent every year

Exclusion Criteria:

• complicated with certain brain disease, including tumor,injury,cerebrovascular disease

• complicated with other severe disease, including cancers, organ failure, heart diseases

• Follow-up less than 6 months